Parodis, I.; Åkerström, E.; Sjöwall, C.; Sohrabian, A.; Jönsen, A.; Gomez, A.; Frodlund, M.; Zickert, A.; Bengtsson, A.A.; Rönnelid, J.;
et al. Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus. Int. J. Mol. Sci. 2020, 21, 3463.
https://doi.org/10.3390/ijms21103463
AMA Style
Parodis I, Åkerström E, Sjöwall C, Sohrabian A, Jönsen A, Gomez A, Frodlund M, Zickert A, Bengtsson AA, Rönnelid J,
et al. Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 2020; 21(10):3463.
https://doi.org/10.3390/ijms21103463
Chicago/Turabian Style
Parodis, Ioannis, Emil Åkerström, Christopher Sjöwall, Azita Sohrabian, Andreas Jönsen, Alvaro Gomez, Martina Frodlund, Agneta Zickert, Anders A Bengtsson, Johan Rönnelid,
and et al. 2020. "Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus" International Journal of Molecular Sciences 21, no. 10: 3463.
https://doi.org/10.3390/ijms21103463
APA Style
Parodis, I., Åkerström, E., Sjöwall, C., Sohrabian, A., Jönsen, A., Gomez, A., Frodlund, M., Zickert, A., Bengtsson, A. A., Rönnelid, J., & Gunnarsson, I.
(2020). Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus. International Journal of Molecular Sciences, 21(10), 3463.
https://doi.org/10.3390/ijms21103463